Researchers at The University of Queensland (UQ) are testing a new drug that may possibly reverse or slow the development of asthma.
Researchers have characterized and revealed the impact of some of the known genetic mutations that have been identified in the CFTR gene and contribute to the development of cystic fibrosis.
A team of scientists conducting a study to examine COPD development at the cellular level demonstrated that free radicals could reach the endoplasmic reticulum and alter its function.
Radius-7 is lightweight, weighing only 0.34 lbs, and attaches to the arm, thus allowing untethered monitoring whether a patient is in or out of bed.
Novartis announced positive data from the FLAME study evaluating the efficacy of the once-daily Ultibro Breezhaler for reducing COPD exacerbations.
A new pilot project at St. Paul's Hospital in Canada will follow COPD patients after their release from the hospital to teach them better disease management.
The adoption of a multiplex respiratory virus testing platform did not significantly reduce antibiotic prescriptions among those with other noninfluenza respiratory pathogens.
According to a study, younger COPD patents and those who are socioeconomically disadvantaged are less likely to quit smoking than older, more affluent patients.
A new paper indicates that there is no proof of the added benefit of using umeclidinium bromide for symptom relief in COPD patients.
A new study indicates that there is little awareness of the chemical components of cigarette smoke among US adults despite having looked for relevant information.
Researchers found that the number of individuals with COPD who received PR increased from 2.6% in 2003 to 3.7% in 2012.
Electronic cigarette makers and sellers are making all kinds of health claims, many of which likely won't stand up to scrutiny under recently announced FDA regulation, a new study has found.
Data from 2013 through 2016 found that FluMist offered children aged 2 to 17 virtually no protection against the flu.
Users can place the device, called FitSleep, under their pillow or mattress in order to track various aspects of their sleeping pattern.
The American Academy of Sleep Medicine (AASM) has released official recommendations for the amount of sleep needed to promote optimal health in children and teens.
The drug candidate, Mul-1867, has shown promise in treating the mixed bacterial and fungal infections found in cystic fibrosis (CF) patients, according to new data.
Forty-nine patients and healthcare workers in a Saudi Arabia hospital were exposed to Middle East respiratory syndrome (MERS) after the disease was not immediately identified in a female patient.
Maxtec has released the MaxO2 ME Oxygen Monitor, which includes a back lit LCD, smart alarms, extended battery life, and other features.
AffloVest has received marketing approvals via CE Mark, Health Canada, and Australian TGA, according to International Biophysics Corp.
The VisiVest System the world's first airway clearance therapy system combining high-frequency chest-wall oscillation with wireless connectivity.